Combines Synopsis Solicitation- iPSC Differentiati
Closed Solicitation Posted
- Solicitation number
- 75N98026Q00878
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of the Director, Office of Acquisitions, intends to award a firm fix-price contract on a non-competitive basis to Oxford StemTech Ltd for scientific support services in quality control and characterization of Induced Pluripotent Stem Cells and organoids, with proposals due July 31, 2026 at 2:00 PM EST. This is a non-competitive combined synopsis/solicitation under FAR 12.603 and does not exceed the simplified acquisition threshold.
Place of performance is 4D18, Building 10, 10 Center Drive, Bethesda, Maryland. The work encompasses two phases: Phase 1 requires quality assessment of 94 iPSC lines representing 2 lines each from 47 individuals across 9 karyotype groups (XO, XX, XXX, XXXX, XY, XXY, XYY, XXYY, and XXXXY), with two cryovials per line. Phase 2 involves generation and characterization of organoids from 26 selected iPSC lines, including organoid differentiation, assembloid formation, MEA assays, and single-cell RNA sequencing library preparation. Deliverables include E8 culture conversion, cryopreservation, embryoid body formation, differentiation assays, microscopy images, growth data, neuronal activity assessments, and prepared sequencing libraries shipped to NIH. The period of performance shall not exceed 12 months from contract award. NAICS code is 541714, Research and Development in Biotechnology (except Nanobiotechnology). PSC code is Q301, Reference Laboratory Testing. Responses must include UEI, TIN, business size certification, and demonstrate capability through past performance, technical capability, and relevant experience. All offerors must be actively registered in SAM. Contact John Johnson, Program Specialist, 667-312-5580, johnsonjr@mail.nih.gov.
Notice text
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00878/PCA-NIMH-02470. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Oxford StemTech Ltd The Oxford Science Park Hayakawa Building Edmund Hally Road Oxford, UK to acquire scientific support services for the quality control of Induced Pluripotent Stem Cells (iPSCs) and use of a subset of these iPSC lines for generation and characterization of organoids.
Files
| File | Type | Posted |
|---|---|---|
| Sol_75N98026Q00878.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOI - A Non-Invasive Prognostic Biomarker | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside | |
| Combines Synopsis Solicitation- Automated Spatial | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity